These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3292105)

  • 41. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide.
    Corder CN; Goldberg MR; Alaupovic PA; Price MD; Furste SS
    Eur J Clin Pharmacol; 1992; 42(1):65-70. PubMed ID: 1541318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
    Massie BM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S55-8. PubMed ID: 2468874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients.
    Batey DM; Nicolich MJ; Lasser VI; Jeffrey SS; Lasser NL
    Am J Med; 1989 Jan; 86(1B):74-8. PubMed ID: 2643866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term effects of pinacidil in hypertensive dialysis patients.
    Breen EG; Mulhall D; Keogh JA
    Eur J Clin Pharmacol; 1985; 28(4):375-80. PubMed ID: 4029243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous pinacidil in the acute treatment of hypertension.
    Rijk MC; Thien T
    J Clin Pharmacol; 1987 Jul; 27(7):468-74. PubMed ID: 3308975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of pinacidil in patients with primary Raynaud's phenomenon.
    Dompeling EC; Smit AJ
    Vasa Suppl; 1992; 34():34-7. PubMed ID: 1529416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. II. The results of combined therapy. Side effects. The reasons for dropouts. Conclusion].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(8):35-41. PubMed ID: 1792613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N"-Cyano-N-4-pyridyl-N'-1,2,2-trimethyl-propylguanidine, a new vasodilating agent: acute effect of blood pressure and pharmacokinetics in hypertensive patients.
    Kardel T; Hilden T; Carlsen J; Trap-Jensen J
    J Cardiovasc Pharmacol; 1981; 3(5):1002-7. PubMed ID: 6168845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicardipine and hydrochlorothiazide in essential hypertension.
    Fagan TC; Brown R; Schnaper H; Smolens P; Montijo M; Michelson E; Conrad KA; Lessem J; Freedman D
    Clin Pharmacol Ther; 1989 Apr; 45(4):429-38. PubMed ID: 2649300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment.
    Stone CK; Wellington KL; Willick A; Sullebarger JT; Liang CS
    J Clin Pharmacol; 1991 Apr; 31(4):333-41. PubMed ID: 2037705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of hypotensive and hemodynamic effects of prazosin in patients with hypertension].
    Ostapiuk FE; Dobrotvorskaia TE; Samofanova MS; Shengeliia RG
    Kardiologiia; 1986 Mar; 26(3):45-9. PubMed ID: 3520086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    JAMA; 1982 Oct; 248(16):2004-11. PubMed ID: 6750167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y
    Drugs; 1988; 35 Suppl 6():156-63. PubMed ID: 3042355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension.
    Steensgaard-Hansen F; Carlsen JE
    Drugs; 1988; 36 Suppl 7():70-6. PubMed ID: 3254831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.